Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06529367

Comparing a Home Vision Self-Assessment Test to Office-Based Snellen Visual Acuity in Myopic Children

Status
Recruiting
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
South Valley University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare a home vision self-assessment test to office-based Snellen visual acuity in myopic children.

Detailed description

Visual impairment is an important public health issue worldwide, with a heavy socioeconomic burden. More than 400 million people globally have mild to severe visual impairment. Visual acuity (VA) screening is the most basic part of ophthalmic examination. Home vision screening tests have become an important way to obtain a measure of an individual's VA without an office-based clinic visit. Knowing a patient's VA can help ophthalmologists remotely triage acute calls, monitor visual recovery after medical or surgical interventions, and ensure visual stability in follow-up telemedicine visits. Home vision screening tests have become an important way to obtain a measure of an individual's VA without an office-based clinic visit. Numerous electronic home vision assessment tools exist, but many of these are used through applications on mobile or tablet devices.

Conditions

Interventions

TypeNameDescription
OTHERSnellen chartPatients will be asked to use the 5 feet distance for standardization, which allows for visual acuity assessment from 20/16 to 20/200. Patients will be asked to wear their current corrective lens for distance, to take the test at home in a place with good lighting and to test each eye separately. Office-based vision testing will be performed by a trained ophthalmic technician in a dimmed room with the Snellen chart illuminated on a screen. Patients will be asked to wear their current corrective lens for distance and an eye occluder will be used to test each eye separately.

Timeline

Start date
2024-07-31
Primary completion
2025-02-01
Completion
2025-02-01
First posted
2024-07-31
Last updated
2024-08-01

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06529367. Inclusion in this directory is not an endorsement.